Skip to main content
. 2021 May 26;9(6):554. doi: 10.3390/vaccines9060554

Figure 4.

Figure 4

Cytopathic signs observed in ExpiSf9TM cells. (a) ExpiSf9TM cells (×10). (b) Transfected ExpiSf9TM cells (×10). (c) ExpiSf9TM cells with visible signs of virus infection (× 40).